BriefCase-Triage

Aidoc Medical's BriefCase-Triage is a radiological computer-aided triage software designed to streamline workflow for medical specialists by flagging suspected Aortic Dissection in CT scans. It leverages an artificial intelligence algorithm to analyze images in parallel with standard interpretation, demonstrating high sensitivity and specificity in providing rapid notifications for critical cases.

Aidoc Medical, Ltd. has developed BriefCase-Triage, a radiological computer-aided triage and notification software designed to assist medical specialists. This software analyzes CT chest, abdomen, or chest/abdomen exams with contrast (CTA and CT with contrast) for adults and transitional adolescents aged 18 and older. Its primary purpose is to aid hospital networks and appropriately trained medical specialists in workflow triage by flagging and communicating suspected positive findings of Aortic Dissection (AD) pathology. The BriefCase-Triage system uses an artificial intelligence algorithm to analyze images and highlight cases with detected findings, presenting users with notifications that include compressed preview images for informational purposes only, not for diagnosis. It operates in parallel to the standard image interpretation process, ensuring that the original medical images are not altered and no cases are removed from the standard workflow. Performance data indicates a sensitivity of 92.7% and a specificity of 92.8%, with a mean time-to-notification of 10.7 seconds, demonstrating its effectiveness in providing timely alerts for critical cases and aiding in worklist prioritization.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. Given the 92.7% sensitivity, what are the characteristics of the 7.3% of missed Aortic Dissection cases, and what are the potential clinical implications of these false negatives?; How does the BriefCase-Triage system integrate into existing PACS/RIS workflows, and what are the infrastructure requirements for optimal deployment and performance in various hospital networks?; Beyond Aortic Dissection, what other critical pathologies could this AI algorithm be trained to detect, and what is the roadmap for expanding its diagnostic capabilities?; What post-market surveillance or real-world evidence studies are planned or ongoing to further validate the system's performance and impact on patient outcomes over a longer period?; How does the system handle cases with subtle or atypical presentations of Aortic Dissection, and what mechanisms are in place to prevent over-reliance on the AI's notification in complex scenarios?